Alfuzosin Hydrochloride
- Product NDC
- 47335-956
- 11-digit product format
- 473350956
- Labeler code
- 47335
- Product ID
- 47335-956_70258299-7c72-4a10-8d0c-4a5e3b2a0fc8
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Alfuzosin Hydrochloride
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- Sun Pharmaceutical Industries, Inc.
- Application
- ANDA079057
- Marketing category
- ANDA
- Marketing start
- 2011-11-22
- Substance
- ALFUZOSIN HYDROCHLORIDE
- Active strength
- 10 mg/1
- Pharmacologic classes
- Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Alfuzosin Hydrochloride
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| ALFUZOSIN HYDROCHLORIDE | 10 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 75046A1XTN |
| Rxcui | 861132 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 47335-956-08 | Alfuzosin Hydrochloride | 100 in 1 BOTTLE | TABLET, EXTENDED RELEASE | 100 | | 15 |
| 47335-956-18 | Alfuzosin Hydrochloride | 1000 in 1 BOTTLE | TABLET, EXTENDED RELEASE | 1000 | | 15 |
| 47335-956-81 | Alfuzosin Hydrochloride | 90 in 1 BOTTLE | TABLET, EXTENDED RELEASE | 90 | | 15 |
| 47335-956-83 | Alfuzosin Hydrochloride | 30 in 1 BOTTLE | TABLET, EXTENDED RELEASE | 30 | | 15 |
| 47335-956-88 | Alfuzosin Hydrochloride | 100 in 1 BOTTLE | TABLET, EXTENDED RELEASE | 100 | | 15 |
DailyMed Socrata Ingredients#
Ingredient, Type, UNII table| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|
| ALFUZOSIN HYDROCHLORIDE | ACTIVE INGREDIENT | 75046A1XTN | ALFUZOSIN HYDROCHLORIDE TABLET, EXTENDED RELEASE [SUN PHARMA GLOBAL FZE] | 8 | |
| ALFUZOSIN | ACTIVE MOIETY | 90347YTW5F | ALFUZOSIN HYDROCHLORIDE TABLET, EXTENDED RELEASE [SUN PHARMA GLOBAL FZE] | 8 | |
| DIMETHYLAMINOETHYL METHACRYLATE - BUTYL METHACRYLATE - METHYL METHACRYLATE COPOLYMER | INACTIVE INGREDIENT | 905HNO1SIH | ALFUZOSIN HYDROCHLORIDE TABLET, EXTENDED RELEASE [SUN PHARMA GLOBAL FZE] | 8 | |
| HYDROXYPROPYL CELLULOSE (TYPE H) | INACTIVE INGREDIENT | RFW2ET671P | ALFUZOSIN HYDROCHLORIDE TABLET, EXTENDED RELEASE [SUN PHARMA GLOBAL FZE] | 8 | |
| HYPROMELLOSES | INACTIVE INGREDIENT | 3NXW29V3WO | ALFUZOSIN HYDROCHLORIDE TABLET, EXTENDED RELEASE [SUN PHARMA GLOBAL FZE] | 8 | |
| MAGNESIUM STEARATE | INACTIVE INGREDIENT | 70097M6I30 | ALFUZOSIN HYDROCHLORIDE TABLET, EXTENDED RELEASE [SUN PHARMA GLOBAL FZE] | 8 | |
| SILICON DIOXIDE | INACTIVE INGREDIENT | ETJ7Z6XBU4 | ALFUZOSIN HYDROCHLORIDE TABLET, EXTENDED RELEASE [SUN PHARMA GLOBAL FZE] | 8 | |
| STARCH, CORN | INACTIVE INGREDIENT | O8232NY3SJ | ALFUZOSIN HYDROCHLORIDE TABLET, EXTENDED RELEASE [SUN PHARMA GLOBAL FZE] | 8 | |
| TALC | INACTIVE INGREDIENT | 7SEV7J4R1U | ALFUZOSIN HYDROCHLORIDE TABLET, EXTENDED RELEASE [SUN PHARMA GLOBAL FZE] | 8 | |
| ALFUZOSIN HYDROCHLORIDE | ACTIVE INGREDIENT | 75046A1XTN | ALFUZOSIN HYDROCHLORIDE TABLET, EXTENDED RELEASE [AIDAREX PHARMACEUTICALS LLC] | 2 | |
| ALFUZOSIN | ACTIVE MOIETY | 90347YTW5F | ALFUZOSIN HYDROCHLORIDE TABLET, EXTENDED RELEASE [AIDAREX PHARMACEUTICALS LLC] | 2 | |
| DIMETHYLAMINOETHYL METHACRYLATE - BUTYL METHACRYLATE - METHYL METHACRYLATE COPOLYMER | INACTIVE INGREDIENT | 905HNO1SIH | ALFUZOSIN HYDROCHLORIDE TABLET, EXTENDED RELEASE [AIDAREX PHARMACEUTICALS LLC] | 2 | |
| HYDROXYPROPYL CELLULOSE (TYPE H) | INACTIVE INGREDIENT | RFW2ET671P | ALFUZOSIN HYDROCHLORIDE TABLET, EXTENDED RELEASE [AIDAREX PHARMACEUTICALS LLC] | 2 | |
| HYPROMELLOSES | INACTIVE INGREDIENT | 3NXW29V3WO | ALFUZOSIN HYDROCHLORIDE TABLET, EXTENDED RELEASE [AIDAREX PHARMACEUTICALS LLC] | 2 | |
| MAGNESIUM STEARATE | INACTIVE INGREDIENT | 70097M6I30 | ALFUZOSIN HYDROCHLORIDE TABLET, EXTENDED RELEASE [AIDAREX PHARMACEUTICALS LLC] | 2 | |
| SILICON DIOXIDE | INACTIVE INGREDIENT | ETJ7Z6XBU4 | ALFUZOSIN HYDROCHLORIDE TABLET, EXTENDED RELEASE [AIDAREX PHARMACEUTICALS LLC] | 2 | |
| STARCH, CORN | INACTIVE INGREDIENT | O8232NY3SJ | ALFUZOSIN HYDROCHLORIDE TABLET, EXTENDED RELEASE [AIDAREX PHARMACEUTICALS LLC] | 2 | |
| TALC | INACTIVE INGREDIENT | 7SEV7J4R1U | ALFUZOSIN HYDROCHLORIDE TABLET, EXTENDED RELEASE [AIDAREX PHARMACEUTICALS LLC] | 2 | |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 47335-956 | ALFUZOSIN HYDROCHLORIDE TABLET, EXTENDED RELEASE [SUN PHARMACEUTICAL INDUSTRIES, INC.] | 15 | Current NDC, Legacy NDC, 5 package rows | 20240120_d2af616e-673a-4fdd-ace8-db2d0f154604.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 47335-956-08 | 47335095608 | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (47335-956-08) | 2011-11-22 | 0000-00-00 | No | No | Current |
| 47335-956-18 | 47335095618 | 1000 TABLET, EXTENDED RELEASE in 1 BOTTLE (47335-956-18) | 2011-11-22 | 0000-00-00 | No | No | Current |
| 47335-956-81 | 47335095681 | 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (47335-956-81) | 2011-11-22 | 0000-00-00 | No | No | Current |
| 47335-956-83 | 47335095683 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (47335-956-83) | 2011-11-22 | 0000-00-00 | No | No | Current |
| 47335-956-88 | 47335095688 | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (47335-956-88) | 2011-11-22 | 0000-00-00 | No | No | Current |